WSD Medi

Warsaw 02-786

6 studies enrolling now · 6 studies all time

What they study most

Carcinoma, Transitional Cell, Colitis, Ulcerative, Crohn Disease, Crohn's Disease, Diarrhea, Inflammatory Bowel Diseases, Irritable Bowel Syndrome, Neoplasm Metastasis, Ulcerative Colitis, Urinary Bladder Neoplasms

Studies at this site

• LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis: — Recruiting now
• A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease — Recruiting now
• A Study of LY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab (Alone) in Adults With Crohn's Disease — Recruiting now
• A Study of Brenipatide (LY3537031) in Participants With Irritable Bowel Syndrome-Diarrhea (IBS-D) — Recruiting now
• A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease — Recruiting now
• A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract — Recruiting now